NOOR Collagen U.S. Revenue Projected Over $12M for Cosmos Health; Company Reports Record Momentum, No Mideast Conflict Impact
COSM is trading near its 52-week low of $0.28 (2.8% above the low).
Summary
Cosmos Health announced that its NOOR collagen product is on track to generate over $12 million in U.S. revenue within the next 12 months, with anticipated gross margins of approximately 75%. The company also reported continued record revenue momentum, with Q3 2025 revenue reaching an all-time high of $17.1 million, a 38% year-over-year increase, and confirmed no material impact from the ongoing Middle East conflict on its operations. This significant revenue projection for a single product, especially for a company with a market capitalization of around $10 million, represents a substantial growth catalyst and provides strong forward guidance. The news follows recent product development announcements for C-Scrub Wash and Liv18, indicating active business expansion. Investors will be watching for the forthcoming Q4 and full-year 2025 results for more detailed financial information and confirmation of this momentum.
At the time of this announcement, COSM was trading at $0.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.8M. The 52-week trading range was $0.28 to $1.32. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Access Newswire.